Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

23andMe Holding Co. T.ME


Primary Symbol: ME

23andMe Holding Co. is a genetics-led consumer healthcare and biopharmaceutical company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patients’ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.


NDAQ:ME - Post by User

Comment by idlefreebirdon May 20, 2022 12:47pm
351 Views
Post# 34698703

RE:i know

RE:i knowctm...the holt mine wich was ST-andrews and got bought ut by KL and now Agnico is further down the road and won't be feasible for Moneta's operation..Holt is a 3500 tpd capacity mill and way to far down the road to run low grade ore..Moneta will be looking at a 30,000 tpd operation to get a 300,000 ounce a year production..Northern Gold did run ore  from a bulk sample of Garcon pit with great success and 95% recoveries ...therefore a mill is required on site to be a 300,000 ounce producer..glta
<< Previous
Bullboard Posts
Next >>